BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25389654)

  • 41. Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects.
    McNulty B; Pentieva K; Marshall B; Ward M; Molloy AM; Scott JM; McNulty H
    Hum Reprod; 2011 Jun; 26(6):1530-6. PubMed ID: 21441543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is folic acid supplementation really necessary in preterm infants ≤ 32 weeks of gestation?
    Oncel MY; Calisici E; Ozdemir R; Yurttutan S; Erdeve O; Karahan S; Dilmen U
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):188-92. PubMed ID: 24051483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention.
    Berry RJ; Li Z; Erickson JD; Li S; Moore CA; Wang H; Mulinare J; Zhao P; Wong LY; Gindler J; Hong SX; Correa A
    N Engl J Med; 1999 Nov; 341(20):1485-90. PubMed ID: 10559448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of folic acid.
    Berg MJ
    J Gend Specif Med; 1999; 2(3):24-8. PubMed ID: 11252849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of supplementation with folic acid throughout pregnancy on plasma homocysteine concentration.
    Ellison J; Clark P; Walker ID; Greer IA
    Thromb Res; 2004; 114(1):25-7. PubMed ID: 15262481
    [No Abstract]   [Full Text] [Related]  

  • 46. Folate intake and the risk of neural tube defects: an estimation of dose-response.
    Moore LL; Bradlee ML; Singer MR; Rothman KJ; Milunsky A
    Epidemiology; 2003 Mar; 14(2):200-5. PubMed ID: 12606886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Justifying the "Folate trap" in folic acid fortification programs.
    Mahajan NN; Mahajan KN; Soni RN; Gaikwad NL
    J Perinat Med; 2007; 35(3):241-2. PubMed ID: 17480154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implementation and outcomes of recommended folic acid supplementation in Mexican-American women with prior neural tube defect-affected pregnancies.
    Felkner M; Suarez L; Hendricks K; Larsen R
    Prev Med; 2005 Jun; 40(6):867-71. PubMed ID: 15850889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peri-conception use of folic acid in the prevention of neural tube defect: current concepts].
    García-Morales MA; Limón-Luque LM; Barrón-Vallejo J; González-Morales ME; Kably-Ambe A
    Ginecol Obstet Mex; 1996 Sep; 64():418-21. PubMed ID: 8964544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service.
    Goldberg BB; Alvarado S; Chavez C; Chen BH; Dick LM; Felix RJ; Kao KK; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):193-9. PubMed ID: 16511885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association Between Maternal Folic Acid Supplementation and Congenital Heart Defects in Offspring in Birth Cohorts From Denmark and Norway.
    Øyen N; Olsen SF; Basit S; Leirgul E; Strøm M; Carstensen L; Granström C; Tell GS; Magnus P; Vollset SE; Wohlfahrt J; Melbye M
    J Am Heart Assoc; 2019 Mar; 8(6):e011615. PubMed ID: 30857459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the association between maternal folic acid supplementation and the risk of congenital heart disease: a systematic review and meta-analysis.
    Cheng Z; Gu R; Lian Z; Gu HF
    Nutr J; 2022 Mar; 21(1):20. PubMed ID: 35346212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Folic acid supplementation in pregnancy and prevention of fetal neural tube defects.
    Wierzejska R; Wojda B
    Przegl Epidemiol; 2020; 74(2):362-369. PubMed ID: 33115226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps.
    Botto LD; Mulinare J; Erickson JD
    Am J Med Genet A; 2003 Aug; 121A(2):95-101. PubMed ID: 12910485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-Trimester Maternal Folic Acid Supplementation Reduced Risks of Severe and Most Congenital Heart Diseases in Offspring: A Large Case-Control Study.
    Qu Y; Lin S; Zhuang J; Bloom MS; Smith M; Nie Z; Mai J; Ou Y; Wu Y; Gao X; Tan H; Liu X
    J Am Heart Assoc; 2020 Jul; 9(13):e015652. PubMed ID: 32613868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of neural tube defects: what is the effect of polymorphism in folate metabolism? Prevention with folic acid and folate].
    Queisser-Luft A
    Kinderkrankenschwester; 2008 Sep; 27(9):385-6. PubMed ID: 18841643
    [No Abstract]   [Full Text] [Related]  

  • 57. The Folic Acid Rescue Strategy: High-Dose Folic Acid Supplementation in Early Pregnancy.
    Amitai Y; Koren G
    JAMA Pediatr; 2015 Dec; 169(12):1083-4. PubMed ID: 26436721
    [No Abstract]   [Full Text] [Related]  

  • 58. Lack of association between folate receptor autoantibodies and conotruncal congenital heart defects.
    Lewandowski LB; Sanghavi D
    Pediatr Cardiol; 2013 Mar; 34(3):512-7. PubMed ID: 22915140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metafolin--alternative for folate deficiency supplementation in pregnant women].
    Seremak-Mrozikiewicz A
    Ginekol Pol; 2013 Jul; 84(7):641-6. PubMed ID: 24032278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics.
    Linask KK; Huhta J
    Curr Opin Pediatr; 2010 Oct; 22(5):561-6. PubMed ID: 20844350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.